Cargando…
Assessing the Clinical Benefit of Systemic Adjuvant Therapies for Early Breast Cancer
Oncologic therapy is currently undergoing significant changes. A number of innovative targeted medications currently in clinical development have raised high expectations. With that in mind, discussions about terms such as “clinical benefit” and “clinical relevance” are highly topical. This also app...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Georg Thieme Verlag KG
2017
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658231/ https://www.ncbi.nlm.nih.gov/pubmed/29093601 http://dx.doi.org/10.1055/s-0043-119542 |